Filing Details
Cocrystal Pharma, Inc. (NASDAQ:COCP) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNASDAQ:COCP
Cocrystal Pharma, Inc. (COCP) Reports Material Event to SEC
Filing Details Cocrystal Pharma, Inc. (NASDAQ:COCP) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…
Market Context
Cocrystal Pharma, Inc.'s stock currently trades at $0.95 with a market capitalization of $11.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Cocrystal Pharma, Inc.'s stock.
All SEC filings for Cocrystal Pharma, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View COCP Stock Page
Frequently Asked Questions
Where can I read COCP's SEC filings?
Browse all filings on our COCP SEC filings page.
What types of SEC filings does Cocrystal Pharma, Inc. file?
Public companies like Cocrystal Pharma, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.